Corient Private Wealth’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
+5,049
| New | +$246K | ﹤0.01% | 2197 |
|
|
2025
Q1 | – | Sell |
-8,827
| Closed | -$347K | – | 2315 |
|
|
2024
Q4 | $347K | Sell |
8,827
-365
| -4% | -$14.4K | ﹤0.01% | 1815 |
|
|
2024
Q3 | $432K | Buy |
9,192
+992
| +12% | +$46.6K | ﹤0.01% | 1795 |
|
|
2024
Q2 | $443K | Sell |
8,200
-658
| -7% | -$35.5K | ﹤0.01% | 1706 |
|
|
2024
Q1 | $604K | Buy |
8,858
+58
| +0.7% | +$3.95K | ﹤0.01% | 1534 |
|
|
2023
Q4 | $551K | Sell |
8,800
-546
| -6% | -$34.2K | ﹤0.01% | 1571 |
|
|
2023
Q3 | $424K | Buy |
9,346
+1,699
| +22% | +$77.1K | ﹤0.01% | 1571 |
|
|
2023
Q2 | $429K | Sell |
7,647
-232
| -3% | -$13K | ﹤0.01% | 1520 |
|
|
2023
Q1 | $356K | Buy |
7,879
+707
| +10% | +$32K | ﹤0.01% | 1515 |
|
|
2022
Q4 | $292K | Buy |
+7,172
| New | +$292K | ﹤0.01% | 1341 |
|